BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)

The BARDA DRIVe EZ-BAA is a solicitation for proposals to support the development of medical countermeasures and other technologies to address national health security threats. The EZ-BAA includes multiple Areas of Interest (AOIs), each with its own specific topics and requirements. The AOIs cover a range of topics, including ReDIRECT, Lab at Home, Digital MCMs, Host-Directed Therapeutics, Healing Lungs, DRIVe Forward, Vaccines on Demand, ReBooT, Host-Based Diagnostics, REPAIR, FASTx, Agnostic Diagnostic, Stopping Secondary Spread, and Influenza Vaccine Innovation. Proposers are encouraged to review the EZ-BAA and the specific AOIs to determine which ones align with their interests and capabilities. • The EZ-BAA is open to proposals from a wide range of entities, including small businesses, large businesses, academia, and non-profit organizations. • The proposal process involves submitting a white paper, which will be reviewed by BARDA to determine whether the proposer will be invited to submit a full proposal. • The EZ-BAA includes a plus phase, which allows proposers to request additional funding to support the development of their proposed technology. • The EZ-BAA is subject to amendments, which may change the AOIs, closing dates, or other requirements.